Loading…
← CockpitCompetitor Analysis › 4922.T KOSE Holdings CorporationOpen in the cockpit ↗

KOSE Holdings Corporation4922.TCompetitor analysis, valuation and peers

Japan · JPY·Consumer Staples›Household/Personal Care

Japanese cosmetics maker selling skincare and makeup under brands including KOSE, Sekkisei and Amino Mason.

≈ Japan's Estee LauderMomentum leader 80
Mkt cap
$2.16B
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$12.6M
20-day average traded
Fwd P/E
29.9×
forward earnings
ROIC−WACC
-0.2 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
89 days
15 Feb 2027
Close · JPY¥6,038
1D-2.9%
1W+6.1%
1M+2.0%
3M+5.1%
6M+15.9%
YTD+15.2%
1Y-0.3%
ATR %3.2%
52w lowhigh7.1% off high

What KOSE does

Japanese cosmetics maker selling skincare and makeup under brands including KOSE, Sekkisei and Amino Mason.

Sells through department stores, drugstores, specialty beauty shops, travel retail and online. Premium lines such as Sekkisei are its main route to Chinese shoppers, whether they buy in Japan or in mainland China, while drugstore lines add everyday volume.

In one line: Japan's Estee Lauder.

Products and services

  • Skincare (Sekkisei etc.)
  • Makeup/cosmetics
  • Haircare (Amino Mason)

Customers

  • Retail/department store beauty consumers

Where it sits in the supply chain

  • Consumer beauty
  • Cosmetics manufacturing
  • Skincare, makeup, haircare

What could go right

  • China/Asia travel-retail beauty demand recovery

What could go wrong

  • China consumer demand volatility
  • Cosmetics category competition

Moat: narrow (brand, distribution). Established cosmetics brand portfolio and department-store/travel-retail distribution in Asia.

Headquarters: Tokyo, Japan · Founded: 1946 · Employees: 8,566

Named competitors

KOSE at a glance

Size KOSE (4922.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $2.16B, the 466th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥6,038 on 18 Nov 2026.

Performance Over six months the shares gained 15.9%, against -4.7% for the median peer and -1.4% for the Japan market (cap-weighted) — 5th highest of 21 in its peer set.

Growth Revenue grew 4.5% over the last twelve months (peer median +5.4%); the operating margin is 5.2% (peer median 10.6%).

Valuation It trades at 29.9× forward earnings against a peer median of 20.7× (6th most expensive of 21).

Capital Return on invested capital runs 0.2 points below its cost of capital (5.0% WACC).

Next results Next results expected around 15 Feb 2027 (exchange calendar; dates can move).

Relative performance

10011012021 May 202621 Aug 202618 Nov 20264922.T 114Peer median 97
Six months, rebased to 100: KOSE against the median of its 20 peers (local-currency closes).

KOSE financials

Reported figures in JPY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥339B¥330B¥323B¥300B¥289B
Revenue growth—+2%+7%+4%—
Gross profit¥229B¥222B¥217B¥206B¥201B
EBITDA¥30.2B¥31.0B¥28.4B¥26.9B¥33.3B
Net income¥12.7B¥15.1B¥7.51B¥11.7B¥18.8B
Free cash flown/a-¥5.92B-¥382M¥27.1B¥16.0B
Capital expendituren/a¥21.5B¥21.0B¥5.53B¥7.10B
Total debt¥19.1B¥10.7B¥11.2B¥10.2B¥9.98B

Quarterly statements and history in the cockpit →

KOSE competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%269869931618904927PGHHEMAMILTDENR2367192820300888GILLETTE795630095705190060360560398360031500279030137149674922.T6-month return →1-month return →
Up and to the right = strong over both horizons. KOSE is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×269869931618904927PGHHEMAMILTDENR2367192820300888GILLETTE795630095705190060360560398360031500279030137149674922.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. KOSE is the large dot.

KOSE competitors and peer comparison

Head to head with its named competitors (4922.T vs 4911.T vs 4927.T vs EL)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
KOSE 4922.T$2.16B+16%+4%5%29.9×n/a
Shiseido 4911.T$10.8B+47%+6%6%35.1×12.7%
Pola Orbis 4927.T$2.04B+15%+1%11%30.6×-2.0%
Estée Lauder Companies (The) EL$37.7B+34%+6%13%29.4×16.2%

How KOSE compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

KOSE against its 20 peers (data as of 18 Nov 2026)
Measure4922.TPeer medianRank in peer set
1-month return+2.0%-2.0%10th highest of 21
6-month return+15.9%-4.7%5th highest of 21
Distance from 52-week high-7.1%-26.2%5th highest of 21
Revenue growth (TTM)+4.5%+5.4%11th highest of 21
Operating margin5.2%10.6%5th lowest of 21
Forward P/E29.9×20.7×6th most expensive of 21
ROIC minus cost of capital-0.2 pp+5.4 pp7th lowest of 20
EV / EBITDA10.0×12.3×5th cheapest of 14
Net debt / EBITDA-2.1×-1.8×6th least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
KOSE 4922.TJapan$2.16B+16%+4%5%29.9×n/an/a
Softcare 2698.HKHong Kong$2.20B+5%+25%25%14.4×9.1%+20.9%
Blue Moon 6993.HKHong Kong$2.07B-4%-2%-2%103.3×n/an/a
Kolmar Korea 161890.KSSouth Korea$2.05B+14%+16%10%14.3×-1.6%+15.5%
Pola Orbis 4927.TJapan$2.04B+15%+1%11%30.6×-2.0%-0.7%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.37B-30%-2%24%27.0×21.2%+7.4%
Emami EMAMILTD.NSIndia$1.94B-5%+13%20%23.4×21.5%+5.6%
Energizer ENRUnited States$1.94B+71%0%17%9.1×-5.1%-0.5%
Giant Biogene 2367.HKHong Kong$2.47B-32%-10%32%8.6×-10.7%+34.9%
Cosmax 192820.KSSouth Korea$2.51B+53%+25%8%18.8×n/an/a
Winner Medical 300888.SZChina$2.53B-6%+4%11%19.9×-5.2%-2.6%
Gillette India GILLETTE.NSIndia$2.53B-5%+8%28%37.1×14.9%+13.0%
Pigeon 7956.TJapan$1.76B+26%+8%13%27.9×-2.4%+1.9%
Yunnan Botanee Bio-Technology 300957.SZChina$1.69B-33%+7%9%19.1×2.6%+15.3%
LG H&h 051900.KSSouth Korea$2.81B-14%-3%3%23.1×-4.6%-4.1%
Proya Cosmetics 603605.SSChina$2.87B-13%+2%13%10.9×-5.3%+23.1%
Guangdong Marubi Biotechnology 603983.SSChina$1.62B+9%-6%2%45.5×n/an/a
Shanghai Jahwa United 600315.SSChina$1.61B-15%+9%2%15.4×15.3%-2.1%
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
Kobayashi Pharmaceutical 4967.TJapan$3.25B+20%+2%6%48.7×18.0%+1.9%

Questions

Who are KOSE's main competitors?
Named competitors: Shiseido (4911.T), Pola Orbis Holdings (4927.T), Estee Lauder (EL). The cockpit's measured peer set (industry) also includes Softcare (2698.HK), Blue Moon (6993.HK), Kolmar Korea (161890.KS), Pola Orbis (4927.T), Procter & Gamble Hygiene & Health Care (PGHH.NS), Emami (EMAMILTD.NS).
Is KOSE expensive compared with its peers?
On forward p/e it trades at 29.9× against a peer median of 20.7×, 6th most expensive of 21 in its peer set.
How has KOSE stock performed?
Over six months to 18 Nov 2026 the shares returned +15.9% against -4.7% for the median peer; over one year -0.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.